Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), is a highly aggressive
monogenic cancer driven by SMARCA4 mutations. Here, we report responses to anti-PD1 …

We analyzed whole exome sequencing data in germline DNA from 412 high grade serous
ovarian cancer (HGSOC) cases from The Cancer Genome Atlas Project and identified 5,517 …

Purpose The known epithelial ovarian cancer (EOC) susceptibility genes account for less than
50% of the heritable risk of ovarian cancer suggesting that other susceptibility genes exist. …

Although microdeletions of the long arm of chromosome 17 are being reported with increasing
frequency, deletions of chromosome band 17q24. 2 are rare. Here we report four patients …

The ability to identify the clinical nature of the recurrent duplication of chromosome 17q12
has been limited by its rarity and the diverse range of phenotypes associated with this …

Cancer cells often exhibit DNA copy number aberrations and can vary widely in their ploidy.
Correct estimation of the ploidy of single-cell genomes is paramount for downstream …

Introduction: Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and
aggressive malignancy affecting young women. The disease is characterized by a …

Objective Treatment options and associated biomarkers for advanced and recurrent disease
are limited. Endometrial cancers (ECs) with CTNNB1 exon 3 mutations appear to have …

Objective: Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare aggressive
subtype of ovarian cancer that occurs primarily in young women and is characterized by …

Objectives: Overcoming chemoresistance will improve outcomes for all women with tubo-ovarian
carcinomas. Mechanisms of chemoresistance are multifactorial and heterogeneous. …